Loading the SOTA2 catalog…
BIGPRO®
Proprietary protein degrader developed by AnHorn Medicines using its generative AI platform.
What is BIGPRO®?
Proprietary protein degrader developed by AnHorn Medicines using its generative AI platform. BI-functional liGand induced PROteolysis molecules that selectively eliminate disease-driving proteins, with focus on prescription aesthetics and oncology.
Product typeDrug Discovery & Biotech
Pricing ·
Deployment
APINot available
What teams use BIGPRO® for
Autonomous drug design and optimization
Design of small molecular inhibitors
Design of molecular target binders
Design of protein degrader drug molecules
Integrations and access
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Platforms
IntegrationsAPI and webhooks
Languages
Support
What reviewers say
Community reviewsReviews are owned and editable by their authors.
Sign in to reviewLoading community reviews…
Enterprise readiness
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.
firewalls
anti-virus systems
access controls
confidentiality agreements for personnel
Data retention:
Benchmarks and comparisons
Independent benchmarksStructured task results are being verified.
Side-by-side comparisonsComparison workspaces will be available in a later release.
